EMSY Links the BRCA2 Pathway to Sporadic Breast and Ovarian Cancer

Cell

Volumn 115, Issue 5, 2003, Pages 523-535

  Hughes Davies, Luke ^a,b   Huntsman, David ^c   Ruas, Margarida ^a   Fuks, Francois ^a   Bye, Jacqueline ^d   Chin, Suet Feung ^b   Milner, Jonathon ^a   Brown, Lindsay A ^c   Hsu, Forrest ^c   Gilks, Blake ^c   Nielsen, Torsten ^c   Schulzer, Michael ^c   Chia, Stephen ^e   Ragaz, Joseph ^e   Cahn, Anthony ^d   Linger, Lori ^b   Ozdag, Hilal ^b   Cattaneo, Elena ^b   Jordanova, E S ^f   Schuuring, Edward ^f,g   Yu, David S ^b,h   Venkitaraman, Ashok ^b,h   Ponder, Bruce ^b   Doherty, Aidan ⁱ   Aparicio, Samuel ^b   Bentley, David ^d   Theillet, Charles ^j   Ponting, Chris P ^k   Caldas, Carlos ^b   Kouzarides, Tony ^a   more..

^a WELLCOME TRUST SANGER INSTITUTE   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^d WELLCOME TRUST SANGER INSTITUTE   (United Kingdom)

^e 221 Wesbrook Mall ^*  (Canada)

^f LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^g UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^h HUTCHISON MRC RESEARCH CENTRE   (United Kingdom)

ⁱ UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^j CENTRE VAL D AURELLE   (France)

^k UNIVERSITY OF OXFORD   (United Kingdom)

more..

Author keywords

[No Author keywords available]

Indexed keywords

BRCA2 PROTEIN; PROTEIN; PROTEIN EMSY; UNCLASSIFIED DRUG;

ARTICLE; BINDING SITE; BREAST CANCER; CANCER SURVIVAL; CHROMATIN; CHROMOSOME 11Q; CHROMOSOME MAP; CONTROLLED STUDY; DNA DAMAGE; DNA REPAIR; EMBRYO; EXON; GENE ACTIVATION; GENE AMPLIFICATION; GENE DELETION; HUMAN; MOLECULAR DYNAMICS; MOUSE; NONHUMAN; OVARY CANCER; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BINDING; PROTEIN DETERMINATION; PROTEIN FUNCTION; PROTEIN LOCALIZATION;

EID: 10744233204     PISSN: 00928674     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0092-8674(03)00930-9     Document Type: Article

References (37)

1. Ansieau S., Leutz A. The conserved Mynd domain of BS69 binds cellular and oncoviral proteins through a common PXLXP motif. J. Biol. Chem. 277:2002;4906-4910.
2. Bachman K.E., Rountree M.R., Baylin S.B. Dnmt3a and Dnmt3b are transcriptional repressors that exhibit unique localization properties to heterochromatin. J. Biol. Chem. 276:2001;32282-32287.
3. Bannister A.J., Zegerman P., Partridge J.F., Miska E.A., Thomas J.O., Allshire R.C., Kouzarides T. Selective recognition of methylated lysine 9 on histone H3 by the HP1 chromo domain. Nature. 410:2001;120-124.
4. Bekri S., Adelaide J., Merscher S., Grosgeorge J., Caroli-Bosc F., Perucca-Lostanlen D., Kelley P.M., Pebusque M.J., Theillet C., Birnbaum D., Gaudray P. Detailed map of a region commonly amplified at 11q13→q14 in human breast carcinoma. Cytogenet. Cell Genet. 79:1997;125-131.
5. Bochar D.A., Wang L., Beniya H., Kinev A., Xue Y., Lane W.S., Wang W., Kashanchi F., Shiekhattar R. BRCA1 is associated with a human SWI/SNF-related complex. linking chromatin remodeling to breast cancer Cell. 102:2000;257-265.
6. Bornemann D., Miller E., Simon J. Expression and properties of wild-type and mutant forms of the Drosophila sex comb on midleg (SCM) repressor protein. Genetics. 150:1998;675-686.
7. Boyd J., Sonoda Y., Federici M.G., Bogomolniy F., Rhei E., Maresco D.L., Saigo P.E., Almadrones L.A., Barakat R.R., Brown C.L.et al. Clinicopathologic features of BRCA-linked and sporadic ovarian cancer. JAMA. 283:2000;2260-2265.
8. Collins N., Wooster R., Stratton M.R. Absence of methylation of CpG dinucleotides within the promoter of the breast cancer susceptibility gene BRCA2 in normal tissues and in breast and ovarian cancers. Br. J. Cancer. 76:1997;1150-1156.
9. Courjal F., Cuny M., Simony-Lafontaine J., Louason G., Speiser P., Zeillinger R., Rodriguez C., Theillet C. Mapping of DNA amplifications at 15 chromosomal localizations in 1875 breast tumors. Definition of phenotypic groups Cancer Res. 57:1997;4360-4367.
10. Cox D.R. Regression models and life tables. J. Roy. Stat. Soc. 34:1972;187-220.
11. Dobrovic A., Simpfendorfer D. Methylation of the BRCA1 gene in sporadic breast cancer. Cancer Res. 57:1997;3347-3350.
12. Downs J.A., Lowndes N.F., Jackson S.P. A role for Saccharomyces cerevisiae histone H2A in DNA repair. Nature. 408:2000;1001-1004.
13. Fyodorov D.V., Kadonaga J.T. The many faces of chromatin remodeling. SWItching beyond transcription Cell. 106:2001;523-525.
14. Gayther S.A., Pharoah P.D., Ponder B.A. The genetics of inherited breast cancer. J. Mammary Gland Biol. Neoplasia. 3:1998;365-376.
15. Hakimi M.A., Bochar D.A., Chenoweth J., Lane W.S., Mandel G., Shiekhattar R. A core-BRAF35 complex containing histone deacetylase mediates repression of neuronal-specific genes. Proc. Natl. Acad. Sci. USA. 99:2002;7420-7425.
16. Harkin D.P., Bean J.M., Miklos D., Song Y.H., Truong V.B., Englert C., Christians F.C., Ellisen L.W., Maheswaran S., Oliner J.D., Haber D.A. Induction of GADD45 and JNK/SAPK-dependent apoptosis following inducible expression of BRCA1. Cell. 97:1999;575-586.
17. Jacobs S.A., Khorasanizadeh S. Structure of HP1 chromodomain bound to a lysine 9-methylated histone H3 tail. Science. 295:2002;2080-2083.
18. Jones D.O., Cowell I.G., Singh P.B. Mammalian chromodomain proteins. their role in genome organisation and expression Bioessays. 22:2000;124-137.
19. Kaplan E.L., Meier P. Nonparametric estimation from incomplete observations. J. Am. Stat. Assoc. 53:1958;457-481.
20. Kononen J., Bubendorf L., Kallioniemi A., Barlund M., Schraml P., Leighton S., Torhorst J., Mihatsch M.J., Sauter G., Kallioniemi O.P. Tissue microarrays for high-throughput molecular profiling of tumor specimens. Nat. Med. 4:1998;844-847.
21. Lachner M., O'Carroll D., Rea S., Mechtler K., Jenuwein T. Methylation of histone H3 lysine 9 creates a binding site for HP1 proteins. Nature. 410:2001;116-120.
22. Maurer-Stroh S., Dickens N.J., Hughes-Davies L., Kouzarides T., Eisenhaber F., Ponting C.P. The Tudor domain 'Royal Family'. Tudor, plant Agenet, Chromo, PWWP and MBT domains Trends Biochem. Sci. 28:2003;69-74.
23. Milner J., Ponder B., Hughes-Davies L., Seltmann M., Kouzarides T. Transcriptional activation functions in BRCA2. Nature. 386:1997;772-773.
24. Myung K., Pennaneach V., Kats E.S., Kolodner R.D. Saccharomyces cerevisiae chromatin-assembly factors that act during DNA replication function in the maintenance of genome stability. Proc. Natl. Acad. Sci. USA. 100:2003;6640-6645.
25. Nielsen P.R., Nietlispach D., Mott H.R., Callaghan J., Bannister A., Kouzarides T., Murzin A.G., Murzina N.V., Laue E.D. Structure of the HP1 chromodomain bound to histone H3 methylated at lysine 9. Nature. 416:2002;103-107.
26. Nordling M., Karlsson P., Wahlstrom J., Engwall Y., Wallgren A., Martinsson T. A large deletion disrupts the exon 3 transcription activation domain of the BRCA2 gene in a breast/ovarian cancer family. Cancer Res. 58:1998;1372-1375.
27. Ormandy C.J., Musgrove E.A., Hui R., Daly R.J., Sutherland R.L. Cyclin D1, EMS1 and 11q13 amplification in breast cancer. Breast Cancer Res. Treat. 78:2003;323-335.
28. Paull T., Rogakou E.P., Yamazaki V., Kirchgessner C.U., Gellert M., Bonner W.M. A critical role for histone H2AX in recruitment of repair factors to nuclear foci after DNA damage. Curr. Biol. 10:2000;886-895.
29. Pilch D.R., Sedelnikova O.A., Redon C., Celeste A., Nussenzweig A., Bonner W.M. Characteristics of gamma-H2AX foci at DNA double-strand breaks sites. Biochem. Cell Biol. 81:2003;123-129.
30. Risch H.A., McLaughlin J.R., Cole D.E., Rosen B., Bradley L., Kwan E., Jack E., Vesprini D.J., Kuperstein G., Abrahamson J.L.et al. Prevalence and penetrance of germline BRCA1 and BRCA2 mutations in a population series of 649 women with ovarian cancer. Am. J. Hum. Genet. 68:2001;700-710.
31. Schultz D.C., Ayyanathan K., Negorev D., Maul G.G., Rauscher F.J. 3rd. SETDB1. A novel KAP-1-associated histone H3, lysine 9-specific methyltransferase that contributes to HP1-mediated silencing of euchromatic genes by krab zinc-finger proteins Genes Dev. 16:2002;919-932.
32. Shin S., Verma I.M. BRCA2 cooperates with histone acetyltransferases in androgen receptor-mediated transcription. Proc. Natl. Acad. Sci. USA. 100:2003;7201-7206.
33. Smothers J.F., Henikoff S. The HP1 chromo shadow domain binds a consensus peptide pentamer. Curr. Biol. 10:2000;27-30.
34. Stec I., Nagl S.B., van Ommen G.J., den Dunnen J.T. The PWWP domain. A potential protein-protein interaction domain in nuclear proteins influencing differentiation? FEBS Lett. 473:2000;1-5.
35. Venkitaraman A.R. Cancer susceptibility and the functions of BRCA1 and BRCA2. Cell. 108:2002;171-182.
36. Yang L., Mei Q., Zielinska-Kwiatkowska A., Matsui Y., Blackburn M.L., Benedetti D., Krumm A.A., Taborsky G.J. Jr., Chansky H.A. An ERG (Ets-related gene)-associated histone methyltransferase interacts with histone deacetylases 1/2 and transcription co-repressors mSin3A/B. Biochem. J. 369:2003;651-657.
37. Ye Q., Hu Y.F., Zhong H., Nye A.C., Belmont A.S., Li R. BRCA1-induced large-scale chromatin unfolding and allele-specific effects of cancer-predisposing mutations. J. Cell Biol. 155:2001;911-921.